Loading...
•
Mar 31, 2025
GoodRx Q1 2025 Earnings Report
GoodRx reported first quarter 2025 results
Key Takeaways
GoodRx reported a 3% increase in revenue and a significant improvement in net income for the first quarter of 2025 compared to the prior year, exceeding previous Adjusted EBITDA margin guidance. The company maintained its full-year 2025 revenue guidance and raised its Adjusted EBITDA expectations.
Revenue for Q1 2025 increased 3% to $203.0 million compared to $197.9 million in Q1 2024.
Net income for Q1 2025 was $11.1 million, a significant improvement from a net loss of $1.0 million in Q1 2024.
Adjusted EBITDA for Q1 2025 was $69.8 million, an increase from $62.8 million in Q1 2024, with Adjusted EBITDA Margin at 34.4%.
The company repurchased 23.3 million shares for $100.9 million during the quarter and ended with $301.0 million in cash and cash equivalents.
Revenue by Segment
Forward Guidance
For the full year 2025, GoodRx expects revenue between $810 million and $840 million, representing 2% to 6% growth. Adjusted EBITDA is expected to be between $273 million and $287 million, representing approximately 5% to 10% growth. For the second quarter, revenue is expected to be up sequentially from Q1 2025 with Adjusted EBITDA Margin roughly similar to Q1 2025.
Positive Outlook
- Full year 2025 revenue guidance maintained at $810 million to $840 million.
- Full year 2025 Adjusted EBITDA guidance raised to $273 million to $287 million.
- Expected year-over-year revenue growth of 2% to 6% for the full year 2025.
- Expected year-over-year Adjusted EBITDA growth of approximately 5% to 10% for the full year 2025.
- Second quarter revenue expected to increase sequentially from the first quarter.
Challenges Ahead
- Achievement of the upper half of the revenue guidance range is dependent on strategic initiatives.
- Revenue influenced by macro conditions such as consumer confidence and spending trends.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...